Literature DB >> 25113912

Cooperative signaling between homodimers of metabotropic glutamate receptors 1 and 5.

Tatyana N Sevastyanova1, Paul J Kammermeier2.   

Abstract

Metabotropic glutamate receptors (mGluRs) function as dimers. Recent work suggests that mGluR1 and mGluR5 may physically interact, but the nature and functional consequences of this relationship have not been addressed. In this study, the functional and pharmacological consequences of this interaction were investigated. Using heterologous expression of mGluR cDNA in rat sympathetic neurons from the superior cervical ganglion and inhibition of the native calcium currents as an assay for receptor activation, a functional interdependence between mGluR1 and mGluR5 was demonstrated. In neurons coexpressing these receptors, combining a selective mGluR1 competitive antagonist with either an mGluR1- or mGluR5-selective negative allosteric modulator (NAM) BAY36-7620 [(3aS,6aS)-hexahydro-5-methylene-6a-(2-naphthalenylmethyl)-1H-cyclopenta[c]furan-1-one] or MPEP [2-methyl-6-(phenylethynyl)pyridine hydrochloride], respectively, strongly occluded signaling by both receptors to an approximately equal degree. By contrast, in cells coexpressing mGluR1 and mGluR2, combining the same mGluR1 competitive inhibitor with an mGluR1 or mGluR2 NAM yielded partial and full inhibition of the response, respectively, as expected for independently acting receptors. In neurons expressing mGluR1 and mGluR5, the selective NAMs each strongly inhibited the response to glutamate, suggesting that these receptors do not interact as heterodimers, which would not be inhibited by selective NAMs. Finally, evidence for a similar mGluR1/mGluR5 functional dependence is shown in medium spiny striatal neurons. Together, these data demonstrate cooperative signaling between mGluR1 and mGluR5 in a manner inconsistent with heterodimerization, and thus suggest an interaction between homodimers.
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25113912      PMCID: PMC4201138          DOI: 10.1124/mol.114.093468

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  39 in total

1.  Metabotropic glutamate receptors mGluR1alpha and mGluR2/3 display dynamic expression patterns in developing rat striatum.

Authors:  E S Jokel; E R Garduno; M A Ariano; M S Levine
Journal:  Dev Neurosci       Date:  2001       Impact factor: 2.984

2.  Selective actions of novel allosteric modulators reveal functional heteromers of metabotropic glutamate receptors in the CNS.

Authors:  Shen Yin; Meredith J Noetzel; Kari A Johnson; Rocio Zamorano; Nidhi Jalan-Sakrikar; Karen J Gregory; P Jeffrey Conn; Colleen M Niswender
Journal:  J Neurosci       Date:  2014-01-01       Impact factor: 6.167

3.  BAY36-7620: a potent non-competitive mGlu1 receptor antagonist with inverse agonist activity.

Authors:  F Y Carroll; A Stolle; P M Beart; A Voerste; I Brabet; F Mauler; C Joly; H Antonicek; J Bockaert; T Müller; J P Pin; L Prézeau
Journal:  Mol Pharmacol       Date:  2001-05       Impact factor: 4.436

4.  Cryptic dimer interface and domain organization of the extracellular region of metabotropic glutamate receptor subtype 1.

Authors:  Y Tsuji; Y Shimada; T Takeshita; N Kajimura; S Nomura; N Sekiyama; J Otomo; J Usukura; S Nakanishi; H Jingami
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

5.  Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons.

Authors:  A Pisani; P Gubellini; P Bonsi; F Conquet; B Picconi; D Centonze; G Bernardi; P Calabresi
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

Review 6.  Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system.

Authors:  D D Schoepp
Journal:  J Pharmacol Exp Ther       Date:  2001-10       Impact factor: 4.030

7.  Metabotropic glutamate receptors 1 and 5 differentially regulate CA1 pyramidal cell function.

Authors:  G Mannaioni; M J Marino; O Valenti; S F Traynelis; P J Conn
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

8.  Activation of group I metabotropic glutamate receptors produces a direct excitation and disinhibition of GABAergic projection neurons in the substantia nigra pars reticulata.

Authors:  M J Marino; M Wittmann; S R Bradley; G W Hubert; Y Smith; P J Conn
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

9.  Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor.

Authors:  N Kunishima; Y Shimada; Y Tsuji; T Sato; M Yamamoto; T Kumasaka; S Nakanishi; H Jingami; K Morikawa
Journal:  Nature       Date:  2000-10-26       Impact factor: 49.962

10.  Covalent and noncovalent interactions mediate metabotropic glutamate receptor mGlu5 dimerization.

Authors:  C Romano; J K Miller; K Hyrc; S Dikranian; S Mennerick; Y Takeuchi; M P Goldberg; K L O'Malley
Journal:  Mol Pharmacol       Date:  2001-01       Impact factor: 4.436

View more
  15 in total

Review 1.  Metabotropic glutamate receptor subtype 5: molecular pharmacology, allosteric modulation and stimulus bias.

Authors:  K Sengmany; K J Gregory
Journal:  Br J Pharmacol       Date:  2015-11-11       Impact factor: 8.739

2.  Biased allosteric agonism and modulation of metabotropic glutamate receptor 5: Implications for optimizing preclinical neuroscience drug discovery.

Authors:  Kathy Sengmany; Junaid Singh; Gregory D Stewart; P Jeffrey Conn; Arthur Christopoulos; Karen J Gregory
Journal:  Neuropharmacology       Date:  2016-07-05       Impact factor: 5.250

3.  Molecular Insights into Metabotropic Glutamate Receptor Allosteric Modulation.

Authors:  Karen J Gregory; P Jeffrey Conn
Journal:  Mol Pharmacol       Date:  2015-03-25       Impact factor: 4.436

4.  Kinetic and system bias as drivers of metabotropic glutamate receptor 5 allosteric modulator pharmacology.

Authors:  Kathy Sengmany; Shane D Hellyer; Sabine Albold; Taide Wang; P Jeffrey Conn; Lauren T May; Arthur Christopoulos; Katie Leach; Karen J Gregory
Journal:  Neuropharmacology       Date:  2019-02-11       Impact factor: 5.250

5.  Transcriptional corepressor SIN3A regulates hippocampal synaptic plasticity via Homer1/mGluR5 signaling.

Authors:  Morgan Bridi; Hannah Schoch; Cédrick Florian; Shane G Poplawski; Anamika Banerjee; Joshua D Hawk; Giulia S Porcari; Camille Lejards; Chang-Gyu Hahn; Karl-Peter Giese; Robbert Havekes; Nelson Spruston; Ted Abel
Journal:  JCI Insight       Date:  2020-03-12

6.  mGluR1 and mGluR5 Synergistically Control Cholinergic Synaptic Transmission in the Thalamic Reticular Nucleus.

Authors:  Yan-Gang Sun; Vanessa Rupprecht; Li Zhou; Rajan Dasgupta; Frederik Seibt; Michael Beierlein
Journal:  J Neurosci       Date:  2016-07-27       Impact factor: 6.167

7.  Mechanisms Underlying Enhancement of Spontaneous Glutamate Release by Group I mGluRs at a Central Auditory Synapse.

Authors:  Kang Peng; Xiaoyu Wang; Yuan Wang; Dainan Li; Hai Huang; Yong Lu
Journal:  J Neurosci       Date:  2020-08-12       Impact factor: 6.167

8.  Functional partnership between mGlu3 and mGlu5 metabotropic glutamate receptors in the central nervous system.

Authors:  Luisa Di Menna; Max E Joffe; Luisa Iacovelli; Rosamaria Orlando; Craig W Lindsley; Jèrome Mairesse; Pierre Gressèns; Milena Cannella; Filippo Caraci; Agata Copani; Valeria Bruno; Giuseppe Battaglia; P Jeffrey Conn; Ferdinando Nicoletti
Journal:  Neuropharmacology       Date:  2017-10-25       Impact factor: 5.250

9.  Differences in interactions between transmembrane domains tune the activation of metabotropic glutamate receptors.

Authors:  Jordana K Thibado; Jean-Yves Tano; Joon Lee; Leslie Salas-Estrada; Davide Provasi; Alexa Strauss; Joao Marcelo Lamim Ribeiro; Guoqing Xiang; Johannes Broichhagen; Marta Filizola; Martin J Lohse; Joshua Levitz
Journal:  Elife       Date:  2021-04-21       Impact factor: 8.713

Review 10.  Targeting metabotropic glutamate receptors for the treatment of depression and other stress-related disorders.

Authors:  Shalini Dogra; P Jeffrey Conn
Journal:  Neuropharmacology       Date:  2021-06-25       Impact factor: 5.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.